Monday - December 23, 2024

ALK1 Receptor and Ligand Antagonists and Uses Thereof

2024-11-19

ALEXANDRIA, Virginia, Nov. 19 -- ACCELERON PHARMA INC., Rahway, New Jersey has been assigned a patent (No. US 12144860 B2, initially filed Dec. 9, 2021) developed by five inventors Asya Grinberg, Lexington, Massachusetts; John Knopf, Carlisle, Massachusetts; Robert S. Pearsall, North Reading, Massachusetts; Ravindra Kumar, Acton, Massachusetts; and Jasbir Seehra, Lexington, Massachusetts, for "ALK1 receptor and ligand antagonists and uses thereof." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

ALK1 Receptor and Ligand Antagonists and Uses Thereof

Information Request Form

Copyright Targeted News Service 2024